Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

901 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-15

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children

NCT04318431

Covid19

COMPLETED NA

COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants

NCT04413968

Coronavirus Coronavirus Infection Covid19 +1 more

COMPLETED NA

Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children

NCT04490811

COVID-19

UNKNOWN

Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department

NCT04583189

Covid19

COMPLETED NA

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

NCT04355533

COVID-19 Infection

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronavirus COVID Infection Viral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Child suspected of infection with COVID-19.

Child included with positive included

nasopharyngeal swab

Intervention Type DIAGNOSTIC_TEST

Data collection and nasopharyngeal swab

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nasopharyngeal swab

Data collection and nasopharyngeal swab

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1st Line Consultation in Pediatric Emergencies
* All reasons for consultation during working hours
* Informed and written consent of a parent holder (only 1 authorized companion) and a child of understanding age

Exclusion Criteria

* Refusal of participation by parents/child of decision age
* No membership of a social security scheme (beneficiary or entitled)
* No understanding of French

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No